- Providers
- Conference
ACC 2026
Tempus is a technology company leading the adoption of Al to help providers close care gaps for patients who may have undiagnosed or undertreated cardiovascular disease. We are pleased to share our latest scientific and clinical research findings during the American College of Cardiology 75th Annual Scientific Session & Expo 2026.
Retrospective Analysis of the Tempus ECG-AF Algorithm for Predicting New-Onset Atrial Fibrillation in a Large Health System.
Authors Dr. An Bui (BSMH), Lindsey P. Guirgues (Director of Research Administration, BSMH), Mary Beth Stonich (Heart and Vascular Service Line Coordinator, BSMH), Jill Sunshine (Director of Cardiovascular Services, St. Francis Medical Center), Dr. Miguel Sotelo (Senior Machine Learning Scientist, Tempus), Dr. Linyuan Jing (Senior Staff Machine Learning Scientist, Tempus), Chris Rogers (Senior Director of Strategic Provider Solutions, Tempus), Dr. Paul Nona (Cardiology, Tempus), Dr. Chris Haggerty (VP of Cardiology Research, Tempus), Dr. John Pfeifer (VP of Clinical Cardiology, Tempus), Dr. Brandon Fornwalt (SVP of Cardiology, Tempus), Dr. Brody Wehman (BSMH)
On ALERT: Using Al-Powered EHR Alerts to Fast Track Evidence Based Care for VHD.
ALERT is the largest known multicenter, cluster-randomized trial to date evaluating an automated EHR-based notification system designed to address the undertreatment of significant valvular heart disease and accelerate time to treatment.
Dr. Wayne B. Batchelor, Dr. Brian R. Lindman
Learn more↗Late Breaking Clinical Trial: Automated Notifications To Improve Referral And Treatment Of Severe Aortic Stenosis And Mitral Regurgitation: Outcomes From The Randomized Alert Trial (Featured Clinical Research IV)
Dr. Wayne B. Batchelor, Dr. Brian R. Lindman, Megan Coylewright, V. Antoine Keller, Miguel Sotelo, Dongho Shin, Chris Rogers, Graeme Hickey, Jamie Williams, Myra Fan, Sreekanth Vemulapalli
Schedule a meeting with us
We'll be in touch shortly.